Literature DB >> 35398556

Utility of nasal mucus inflammatory profile as a biomarker of nasal polyp regrowth in aspirin-exacerbated respiratory disease.

Kristen B Corey1, Justin H Turner2, Naweed I Chowdhury2, Rakesh K Chandra2, Ping Li2, Pingsheng Wu3, Katherine N Cahill4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35398556      PMCID： PMC9469779          DOI： 10.1016/j.jaip.2022.03.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  7 in total

1.  Neutrophils are underrecognized contributors to inflammatory burden and quality of life in chronic rhinosinusitis.

Authors:  Eric F Succar; Ping Li; Kim A Ely; Naweed I Chowdhury; Rakesh K Chandra; Justin H Turner
Journal:  Allergy       Date:  2019-10-31       Impact factor: 13.146

2.  Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.

Authors:  Bogdan Jakiela; Jerzy Soja; Krzysztof Sladek; Marek Przybyszowski; Hanna Plutecka; Anna Gielicz; Ana Rebane; Grazyna Bochenek
Journal:  J Allergy Clin Immunol       Date:  2020-08-15       Impact factor: 10.793

3.  Inflammatory heterogeneity in aspirin-exacerbated respiratory disease.

Authors:  William C Scott; Katherine N Cahill; Ginger L Milne; Ping Li; Quanhu Sheng; Li Ching Huang; Spencer Dennis; Jacob Snyder; Ashley M Bauer; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  J Allergy Clin Immunol       Date:  2020-11-12       Impact factor: 10.793

4.  Elevated mucus interleukin-17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis.

Authors:  Nikita Chapurin; Ping Li; Rakesh K Chandra; Justin H Turner; Naweed I Chowdhury
Journal:  Int Forum Allergy Rhinol       Date:  2020-07-23       Impact factor: 3.858

5.  A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men.

Authors:  Whitney W Stevens; Anju T Peters; Lydia Suh; James E Norton; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Leslie C Grammer; Kathleen E Harris; Roderick G Carter; Atsushi Kato; Margrit Urbanek; Robert P Schleimer; Kathryn E Hulse
Journal:  Immun Inflamm Dis       Date:  2015-02-12

Review 6.  Biologic therapies versus surgical management for aspirin-exacerbated respiratory disease: A review of preliminary data, efficacy, and cost.

Authors:  Alan D Workman; Benjamin S Bleier
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-06-23

7.  Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.

Authors:  Michael Yong; Yu Qi Wu; Joel Howlett; Jeromie Ballreich; Evan Walgama; Andrew Thamboo
Journal:  Int Forum Allergy Rhinol       Date:  2021-07-26       Impact factor: 3.858
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.